Avandia :: Endocrinologists respond to Avandia report

Statement from the American Association of Clinical Endocrinologists regarding The New England Journal of Medicine article, ?Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes.?

Menopause :: COX Inhibitors May Weaken Protective Qualities of Estrogen Hormone Therapy

Researchers from the University of Pennsylvania School of Medicine found in a database study of women heart patients that COX inhibitors such as traditional nonsteroidal anti-inflammatory drugs (NSAIDs) may undermine any purported protection against heart disease in participants taking estrogen therapy. The results were described this week in PLoS Medicine.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack